March 10, 2023
This 30 Under 30 Alumna Is One Step Closer To Helping Your Dogs Live Longer
Our mission is to help dogs everywhere live longer, healthier lives.
Loyal is a clinical-stage veterinary medicine company developing drugs intended to extend the healthspan and lifespan of dogs.
Melo
Australian Shepherd
We’re part of Cellular Longevity, a San Francisco-based biotech firm leading pioneering research into the science of longevity.
Learn moreLeadership team
Andrew Bredow
Director,
Engineering
Brennen McKenzie
Director,
Veterinary Medicine
Celine Halioua
Founder & CEO
Dina Juarez-Salinas
Vice President,
Preclinical Development
Ellen Ratcliff
Director,
Clinical Development
John Poisson
Chief Creative Officer
Karen Greenwood
Senior Vice President,
Regulatory & Strategy
Lauren Knight
Director,
Operations
Stacy Ross
Vice President,
Drug Development
Stefan Leape
Chief of Staff
Sudharika Gogna
Vice President,
Operations
Tony Gonzalez
Director,
Analytical Chemistry
Venkata Adapala
Director,
Clinical Operations
Board of Directors
Celine Halioua
Common Director,
Founder/CEO
Laura Deming
Common Director,
Founder/GP Longevity Fund
Josh Kopelman
Board Observer,
First Round Capital
Greg Rosen
Board Observer,
Box Group
Our team
152
Papers published
56
Clinical drug programs worked on
192
Years of research
54%
Women
Backed by the best
Our mission is supported by world-class funds and investors.
Loyal in the news
Announcements
Publications
August, 2022
Extensive Connections of the Canine Olfactory Pathway Revealed by Tractography and Dissection ->
Andrews EF, Pascalau R, Horowitz A, Lawrence GM, Johnson PJ. Extensive Connections of the Canine Olfactory Pathway Revealed by Tractography and Dissection. J Neurosci. 2022 Aug 17;42(33):6392-407.
July, 2022
Evaluating instruments for assessing healthspan: a multi-center cross-sectional study on health-related quality of life (HRQL) and frailty in the companion dog ->
Chen FL, Ullal TV, Graves JL, Ratcliff ER, Naka A, McKenzie B, Carttar TA, Super KM, Austriaco J, Weber SY, LaCroix-Fralish ML. Evaluating instruments for assessing healthspan: a multi-center cross-sectional study on health-related quality of life (HRQL) and frailty in the companion dog. bioRxiv. 2022 Jul 21.
June, 2022
The phenotype of aging in the dog: how aging impacts the health and well-being of dogs and their caregivers ->
McKenzie BA, Chen FL, LaCroix-Fralish ML. The phenotype of aging in the dog: how aging impacts the health and well-being of dogs and their caregivers. AVMA. 2022 Jun 1;260(9):963-70.
June, 2022
Comparative veterinary geroscience: mechanism of molecular, cellular, and tissue aging in humans, laboratory animal models, and companion dogs and cats ->
McKenzie BA. Comparative veterinary geroscience: mechanism of molecular, cellular, and tissue aging in humans, laboratory animal models, and companion dogs and cats. AJVR. 2022 Jun 1;83(6).
April, 2022
Canine Geriatric Syndrome: A Framework for Advancing Research in Veterinary Geroscience ->
McKenzie BA, Chen FL, Gruen ME, Olby NJ. Canine Geriatric Syndrome: A Framework for Advancing Research in Veterinary Geroscience. Front. Vet. Sci. 2022 April 21;9:853743.
October, 2021
AdRoit is an accurate and robust method to infer complex transcriptome composition ->
Yang T, Alessandri-Haber N, Fury W, Schaner M, Breese R, LaCroix-Fralish ML, et al. AdRoit is an accurate and robust method to infer complex transcriptome composition. Commun Biol. 2021 Oct 22;4(1):1-4.
September, 2021
Advancing Genetic Selection and Behavioral Genomics of Working Dogs Through Collaborative Science ->
Chen FL, Zimmermann M, Hekman JP, Lord KA, Logan B, Russenberger J, et al. Advancing Genetic Selection and Behavioral Genomics of Working Dogs Through Collaborative Science. Front. Vet. Sci. 2021 Sept 6;8:662429.
Help us develop the first dog longevity drugs.
Interested in partnering with us?
Contact usLearn where Loyal can take your career.
Join our team